Gastroenterology
Volume 136, Issue 1 , Pages 32-34 , January 2009

Celiac Disease and Its Complications: A Time Traveller's Perspective

  • Joe West

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Joe West, Division of Epidemiology and Public Health, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK

References 

  1. Wells HG. The chronic Argonauts. The Science Schools Journal. 1888;Apr–Jun
  2. Gee S. On the coeliac affection. St Bartholomew's Hospital Reports. 1888;24:17–20
  3. Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217–1225
  4. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128:S79–S86
  5. Gao Y, Kristinsson SY, Goldin , et al. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology. 2008;136:91–98
  6. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA. 2002;287:1413–1419
  7. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98:51–60
  8. Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428–1435
  9. Smedby KE, Akerman M, Hildebrand H, et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut. 2005;54:54–59
  10. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645–646
  11. Kaprio J. Science, medicine, and the future (Genetic epidemiology). BMJ. 2000;320:1257–1259
  12. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95(suppl 1):S144–S150
  13. Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I and type II. Gastroenterology. 2009;136:81–90
  14. Al-Toma A, Verbeek WH, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56:1373–1378
  15. Peters U, Askling J, Gridley G, et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003;163:1566–1572
  16. Solaymani-Dodaran M, West J, Logan RF. Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am J Gastroenterol. 2007;102:864–870
  17. Wall BF, Kendall GM, Edwards AA, et al. What are the risks from medical X-rays and other low dose radiation?. Br J Radiol. 2006;79:285–294
  18. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther. 2004;20:769–775
  19. West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004;329:716–719
  20. Mearin ML, Catassi C, Brousse N, et al. European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol. 2006;18:187–194
  21. Verbeek WH, Van De Water JM, Al-Toma A, et al. Incidence of enteropathy-associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands. Scand J Gastroenterol. 2008;43:1322–1328
  22. Shack LG, Wood HE, Kang JY, et al. Small intestinal cancer in England & Wales and Scotland: time trends in incidence, mortality and survival. Aliment Pharmacol Ther. 2006;23:1297–1306

 The author discloses no conflicts.

PII: S0016-5085(08)02059-3

doi: 10.1053/j.gastro.2008.11.026

Gastroenterology
Volume 136, Issue 1 , Pages 32-34 , January 2009

Article Tools